Welcome to Campus Sanofi Bahrain
Access all the content and events you need to continue growing as a health professional.
Latest trends
Explore the most popular scientific articles and videos among Campus Sanofi users
.png/jcr:content/dupixent%20AD%20summary%20(1).png)
Events
Stay up to date and register for the latest events and view webinar recordings
Support for your patients
Discover the selection of support materials for patients from different therapeutic areas
Sanofi in News
Discover headline news on how Sanofi is engaged with the medical community
.jpg/jcr:content/jcr_content%20(8).jpg)
Our Products
Aubagio®
AUBAGIO® is a once-daily oral tablet that is indicated for adult patients with relapsing remitting multiple sclerosis (RRMS)
Clexane®
Enoxaparin Sodium is a low molecular weight heparin (LMWH) that is administered subcutaneously and used as antithrombotic agent.
Lemtrada®
Lemtrada® is a monoclonal antibody produced in mammalian cells (Chinese Hamster Ovary).
Plavix®
Clopidogrel is an inhibitor of platelet aggregation administered orally and indicated for Secondary prevention of atherothrombotic events.
Renvela®
Sevelamer Carbonate is indicated for the control of hyperphosphatemia in adult patients receiving haemodialysis or peritoneal dialysis. The recommended starting dose of sevelamer carbonate is 2.4 g or 4.8 g per day and must be taken 3 times per day with meals.
Tavanic®
Levofloxacin is used in adults for the treatment of infections. The dosage depends on the type and severity of the infection and the susceptibility of the presumed causative pathogen.
This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.